CoreCap Advisors’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$753 Buy
33
+26
+371% +$667 ﹤0.01% 2721
2026
Q2
$157 Sell
7
-43
-86% -$1.2K ﹤0.01% 3033
2026
Q1
$1.83K Buy
+50
New +$1.97K ﹤0.01% 2427
2025
Q2
– Sell
-9
Closed -$221 – 2781
2025
Q1
$221 Sell
9
-13
-59% -$361 ﹤0.01% 2931
2024
Q4
$629 Buy
22
+13
+144% +$361 ﹤0.01% 2450
2024
Q3
$240 Buy
+9
New +$234 ﹤0.01% 2476

Other funds holding AORT

CoreCap Advisors's AORT Position: Q3 2026 in Review

CoreCap Advisors increased its Artivion (AORT) stake by 371% in Q3 2026, buying an estimated $667 and bringing the position to 33 shares worth $753. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

CoreCap Advisors first reported a position in AORT in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.83K in Q1 2026. 7 funds tracked by Wall St. Rank hold AORT as of Q3 2026.

  • CoreCap Advisors held 33 shares of Artivion worth $753 as of Q3 2026.
  • CoreCap Advisors bought 26 Artivion shares in Q3 2026, an estimated $667.
  • Artivion made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2721 holding.
  • CoreCap Advisors first reported a position in Artivion in Q3 2024 and has held it in 6 quarters since.
  • CoreCap Advisors's Artivion position peaked at $1.83K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Artivion as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.